BeatO is India's largest diabetes solutions platform, offering comprehensive and clinically proven programs to prevent, control, and achieve remission of diabetes. Leveraging innovative technology and the expertise of diabetologists and certified diet coaches, BeatO is dedicated to making diabetes management easier, effective, affordable, and accessible. Founded in 2015, the company operates in the Health Care, Health and Wellness, Insurtech, and Medical Devices industries, with its headquarters in India.
The latest milestone for BeatO was the INR2.69B Series B investment on 16 November 2022, which involved a consortium of notable investors including Blume Ventures, Leo Capital, Orios Venture Partners, Flipkart Ventures, HealthQuad, W Health Ventures, and World Within Ventures. This significant investment underscores the growing recognition and support for BeatO's mission to address the challenges associated with diabetes and indicates a promising future for the company in the healthcare and technology sectors.